Wieskopf, B <br/><br/>
Cyfra 21-1 as a biologic marker of non-small cell lung cancer. Evaluation of sensitivity, specificity, and prognostic role.  [electronic resource] 

 -  Chest  Jul 1995 
 - 163-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0012-3692 
<br/><br/><label>Standard No.: </label>10.1378/chest.108.1.163  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenocarcinoma--blood<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Biomarkers, Tumor--blood<br/>Carcinoma, Non-Small-Cell Lung--blood<br/>Carcinoma, Squamous Cell--blood<br/>Female<br/>Humans<br/>Immunoradiometric Assay<br/>Keratins--blood<br/>Lung Diseases--blood<br/>Lung Neoplasms--blood<br/>Male<br/>Middle Aged<br/>Predictive Value of Tests<br/>Prospective Studies<br/>ROC Curve<br/>Sensitivity and Specificity